Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 135.05 Million CNY | -12.45% |
| 2022 | 154.24 Million CNY | -40.36% |
| 2021 | 258.62 Million CNY | 104.75% |
| 2020 | 126.31 Million CNY | 90.88% |
| 2019 | 66.17 Million CNY | 118.51% |
| 2018 | 30.28 Million CNY | 38.62% |
| 2017 | 21.84 Million CNY | 98.43% |
| 2016 | 11 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 118.29 Million CNY | -4.59% |
| 2024 Q1 | 123.98 Million CNY | -8.2% |
| 2024 Q3 | 115.65 Million CNY | -2.23% |
| 2023 Q1 | 148.63 Million CNY | -3.64% |
| 2023 Q2 | 132.1 Million CNY | -11.12% |
| 2023 Q4 | 135.05 Million CNY | -0.33% |
| 2023 Q3 | 135.49 Million CNY | 2.57% |
| 2023 FY | 135.05 Million CNY | -12.45% |
| 2022 Q4 | 154.24 Million CNY | -39.44% |
| 2022 Q3 | 254.72 Million CNY | -23.26% |
| 2022 Q1 | 346.52 Million CNY | 33.99% |
| 2022 Q2 | 331.9 Million CNY | -4.22% |
| 2022 FY | 154.24 Million CNY | -40.36% |
| 2021 Q2 | 170.42 Million CNY | -50.85% |
| 2021 Q1 | 346.74 Million CNY | 174.52% |
| 2021 FY | 258.62 Million CNY | 104.75% |
| 2021 Q3 | 174.12 Million CNY | 2.17% |
| 2021 Q4 | 258.62 Million CNY | 48.52% |
| 2020 FY | 126.31 Million CNY | 90.88% |
| 2020 Q2 | 99.13 Million CNY | 24.93% |
| 2020 Q3 | 98.11 Million CNY | -1.04% |
| 2020 Q4 | 126.31 Million CNY | 28.74% |
| 2020 Q1 | 79.35 Million CNY | 19.92% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 66.17 Million CNY | 118.51% |
| 2019 Q4 | 66.17 Million CNY | 18.87% |
| 2019 Q3 | 55.66 Million CNY | 20.35% |
| 2019 Q2 | 46.25 Million CNY | 0.0% |
| 2018 Q4 | 30.28 Million CNY | 0.0% |
| 2018 FY | 30.28 Million CNY | 38.62% |
| 2017 FY | 21.84 Million CNY | 98.43% |
| 2016 FY | 11 Million CNY | 0.0% |